Report
Non-drug therapies in Alzheimer´s disease
Report documents
-
Executive summary of the final report
Non-drug therapies in Alzheimer´s disease
-
Final report
Non-drug therapies in Alzheimer´s disease
-
Documentation and appraisal of comments on the preliminary report
Non-drug therapies in Alzheimer´s disease
-
Preliminary report
Non-drug therapies in Alzheimer´s disease
-
Report plan version 2.0
Non-drug therapies in Alzheimer´s disease
-
Documentation and appraisal of comments on the report plan version 1.0
Non-drug therapies in Alzheimer´s disease
-
Amendment 2 to the report plan version 1.0
Non-drug therapies in Alzheimer´s disease
-
Amendment 1 to the report plan version 1.0
Non-drug therapies in Alzheimer´s disease
-
Report plan version 1.0
Non-drug therapies in Alzheimer´s disease
Press releases
Alzheimer’s disease: only a few therapies provide proof of benefit to patients
Cholinesterase inhibitors and ginkgo may alleviate some symptoms – Non-drug approaches are insufficiently investigated – Marked increase in supporting research
Non-drug treatment of Alzheimer’s disease: long-term benefit not proven
Reliable conclusions about the potential for benefit and harm are currently not possible / In general there is still a great need for good studies on non-drug interventions
Additional information
IQWiG health information
Project details
- Project no.
- A05-19D
- Commission
- Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Head and nerves